Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of Cyclosporine in T-Cell Large Granular Lymphocytic Leukemia
Brief Summary:
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic cancer.
PURPOSE: Phase II trial to study the effectiveness of cyclosporine in treating patients who have low blood counts caused by hematologic cancer.